DEPDC1B Is Upregulated in Breast Cancer Tissues and Cells, and the DEPDC1B Expression Level Is Negatively Correlated with the Prognosis of Patients with Breast Cancer. This evidence concerns the gene DEPDC1B and breast carcinoma.